When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
This report contains market size and forecasts of Hemostat Powder in global, including the following market information:
Global Hemostat Powder Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hemostat Powder Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hemostat Powder companies in 2021 (%)
The global Hemostat Powder market was valued at 397.6 million in 2021 and is projected to reach US$ 537.5 million by 2028, at a CAGR of 4.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gelatin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hemostat Powder include Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring, Gelita Medical, Ferrosan Medical Devices, Baxter, Celox and Equimedical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hemostat Powder manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemostat Powder Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostat Powder Market Segment Percentages, by Type, 2021 (%)
Gelatin
Fibrin
Cellulose
Others
Global Hemostat Powder Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostat Powder Market Segment Percentages, by Application, 2021 (%)
Surgical Wound Care
General Wound Care
Global Hemostat Powder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostat Powder Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemostat Powder revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hemostat Powder revenues share in global market, 2021 (%)
Key companies Hemostat Powder sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hemostat Powder sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
C. R. Bard
Pfizer
CSL Behring
Gelita Medical
Ferrosan Medical Devices
Baxter
Celox
Equimedical
Medira
Biocer
Hemostasis
MBP

LEAVE A REPLY

Please enter your comment!
Please enter your name here